Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New gene for rare inherited paralysis may aid other spinal cord research, too

26.09.2003


Discovery holds immediate promise for diagnosis & treatment of hereditary spastic paraplegia



A single mutation in a single gene is enough to slowly rob people of their ability to walk, scientists from the University of Michigan and the University of Pennsylvania report today.

And while the inherited defect itself is rare, its discovery may help researchers unravel the mysteries of much more common paralyzing conditions, from spinal cord injury to Lou Gehrig’s disease.


In a paper published online today in the American Journal of Human Genetics, and scheduled for the journal’s October issue, the U-M and Penn team describes a new gene, called NIPA1, for a form of hereditary spastic paraplegia, or HSP.

HSP is the name given to a group of disorders affecting about 20,000 Americans. HSP gradually disables its victims as long nerve cells in the spinal cord degenerate and muscles weaken and become spastic. It is often misdiagnosed as other nerve disorders, including multiple sclerosis, cerebral palsy, and amyotrophic lateral sclerosis (also called Lou Gehrig’s disease).

There is no cure for HSP, which is also sometimes called familial spastic paraparesis or Strumpell-Lorain disease. Treatment is limited to physical therapy and exercise to help retain as much muscle function as possible, drug treatment to tame spastic muscle movements, and medication to treat patients’ bladder and bowel control problems, and depression.

"There are direct overlaps between this group of diseases and the nerve degeneration processes in other disorders," says senior author John Fink, M.D., professor of neurology at the University of Michigan Medical School, who has devoted his career to studying and treating HSP and related conditions. "Not only do we hope this discovery will aid HSP patients, but we also believe it will aid in understanding and perhaps stopping the fundamental processes involved in other types of spinal cord degeneration."

The newly described gene mutation on chromosome 15 causes a form of HSP that starts in adulthood, and is passed on in families in a pattern called dominant inheritance. The paper’s co-lead authors are U-M research investigator Shirley Rainier, Ph.D., and Penn postdoctoral research fellow Jing-Hua Chai, M.D., who works in the laboratory of co-author Robert D. Nicholls, D.Phil.

The discovery of the mutation was made with the help of two families affected by the disease: one, of Iraqi origin living in Michigan, and the other of Irish descent, living in Arkansas. Affected and unaffected members of both families allowed their DNA to be studied and compared with DNA samples from people without HSP.

The single-nucleotide mutation alters the structure of a protein that the researchers think resides in nerve cell membranes, a feature that may expedite the development of tests and therapies. In addition to further research on the protein’s exact function, this gene discovery could be used to develop a genetic test to help give HSP patients and their families a firm diagnosis and genetic counseling. A provisional patent application has been filed jointly by the U-M and Penn.

The U-M team has previously found other genes involved in HSP, including a mutation responsible for a form of HSP that develops in early childhood and may resemble familial cerebral palsy.

That discovery, of a gene on chromosome 14 that encodes a protein called atlastin, has already yielded a diagnostic test that can give patients a firm diagnosis to tell them if they have or might some day develop that form of HSP. It can also help couples whose family or medical history suggests they might be at risk of passing a dominant form of HSP on to their children; in dominant HSP families, there is a 50 percent risk that each child will develop the condition.

Developed by Athena Diagnostics, which licensed U-M’s patent on the atlastin gene, the test also screens for a form of HSP found by French scientists, based on a gene for a protein called spastin. Fink has no direct financial interest in Athena Diagnostics.

Fink and Rainier have been looking at chromosome 15 for nearly eight years, after discovering that this region contained a mutant HSP gene. Rainier had narrowed the search to a very small region of chromosome 15, and carefully analyzed genes in this region as potential candidates. Meanwhile, Nicholls and his lab had been searching for genes in the same stretch of DNA.

Sharing of information and materials between the two laboratories resulted in the discovery that NIPA1 mutations cause this particularly severe form of HSP. In their paper, the researchers describe the gene and its encoded protein, as well as clinical analysis of affected subjects. The participation of 105 elderly men and women from a U-M Institute of Gerontology registry enabled this study, allowing the investigators to determine the range of normal variations of the new gene.

The affected members of the Iraqi family living in Michigan and the family from Arkansas are among the nearly 400 HSP patients that Fink and his U-M colleagues see each year. The U-M Neurogenetic Disorders Clinic is the largest clinical and research program for HSP and related disorders in the nation, and one of few that offer comprehensive evaluation, including genetic counseling.

The two families are not related, so the researchers believe that the same mutation occurred spontaneously in both, and likely causes the disease in other families and even in patients who have no family history of the disease.

Although more study is needed to understand exactly how the single-nucleotide mutation leads to a dysfunctional protein and thereby to the disabling symptoms of HSP, Fink and his colleagues feel that they have a good chance of unraveling the mystery. They’re working to develop a mouse model of this form of HSP, which will enable further studies of potential drug- and cell-based therapies.

Until this research yields new treatment options, the U-M and a few other centers offer treatment for HSP’s effects, and genetic testing and counseling. Support groups and a new Spastic Paraplegia Foundation bring patients and researchers together locally and nationally. Fink serves as the SPF’s medical advisor and last year hosted the first International Symposium for HSP.


In addition to Rainier, Chai, Fink and Nicholls, U-M laboratory assistant Debra Tokarz is a co-author. The research was supported by Fink’s Veterans Affairs Merit Review grant, the Geriatric Research, Education and Clinical Center of the VA Ann Arbor Healthcare System, and by Nicholls’ grants from the National Institutes of Health and the Muscular Dystrophy Association. American Journal of Human Genetics, Vol. 73, No. 4, Oct. 2003.

Kara Gavin | EurekAlert!
Further information:
http://www.med.umich.edu/1toolbar/whatsnew.htm
http://www.journals.uchicago.edu/AJHG/journal

More articles from Health and Medicine:

nachricht How prenatal maternal infections may affect genetic factors in Autism spectrum disorder
22.03.2017 | University of California - San Diego

nachricht Camouflage apples
22.03.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Pulverizing electronic waste is green, clean -- and cold

22.03.2017 | Materials Sciences

Astronomers hazard a ride in a 'drifting carousel' to understand pulsating stars

22.03.2017 | Physics and Astronomy

New gel-like coating beefs up the performance of lithium-sulfur batteries

22.03.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>